Lilly weight-loss pill Foundayo shows strong first-week demand [USA TODAY]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: USA TODAY
Eli Lilly's LLY.N newly launched weight-loss pill was prescribed 1,390 times in the U.S. in its first week of sales, according to analysts who cited IQVIA data, indicating that its push into oral obesity treatments is gaining early traction. Investors are closely watching the rollout as competition intensifies between Lilly and its Danish rival Novo Nordisk NOVOb.CO for a larger share of the obesity drug market, which is currently dominated by blockbuster injections. "We think Foundayo's initial scripts look excellent," said Jefferies analyst Akash Tewari. Analysts said IQVIA's data for the week ended April 10 is likely based on two days of capture, assuming Foundayo was widely shipped a day earlier. In comparison, Novo's Wegovy pill had hit 3,071 U.S. prescriptions in the first four days after its launch on January 5. Foundayo was approved in the U.S. on April 1, with prescriptions accepted immediately on LillyDirect, while shipping started on April 6. Broad availability t
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Better Long-Term Buy: Eli Lilly or Viking Therapeutics? [Yahoo! Finance]Yahoo! Finance
- Is This the Biggest Game-Changer in Lilly's 150-Year History? [Yahoo! Finance]Yahoo! Finance
- Is This the Biggest Game-Changer in Lilly's 150-Year History? [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Lilly CEO sees weight-loss drugs reaching about half of potential users at peak [Yahoo! Finance]Yahoo! Finance
- Lilly confirms date and conference call for first-quarter 2026 financial results announcement [TheStreet.com]TheStreet.com
LLY
Earnings
- 2/4/26 - Beat
LLY
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/20/26 - Form DEFA14A
- 3/20/26 - Form DEF
- LLY's page on the SEC website